EE200000137A - Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena - Google Patents

Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena

Info

Publication number
EE200000137A
EE200000137A EEP200000137A EEP200000137A EE200000137A EE 200000137 A EE200000137 A EE 200000137A EE P200000137 A EEP200000137 A EE P200000137A EE P200000137 A EEP200000137 A EE P200000137A EE 200000137 A EE200000137 A EE 200000137A
Authority
EE
Estonia
Prior art keywords
inhibitors
neutrophil elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
EEP200000137A
Other languages
English (en)
Estonian (et)
Inventor
Andrew Harrison Lee
George Adam Inglis Graham
Redpath Johnson Martin
John Fawcett Macdonald Simon
Dennis Dowle Michael
Finch Harry
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200000137A publication Critical patent/EE200000137A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
EEP200000137A 1997-09-09 1998-09-07 Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena EE200000137A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9719187.8A GB9719187D0 (en) 1997-09-09 1997-09-09 Compounds
PCT/EP1998/005604 WO1999012931A1 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (1)

Publication Number Publication Date
EE200000137A true EE200000137A (et) 2001-02-15

Family

ID=10818820

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000137A EE200000137A (et) 1997-09-09 1998-09-07 Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena

Country Status (24)

Country Link
US (1) US6228853B1 (is)
EP (1) EP1019406A1 (is)
JP (1) JP2001515902A (is)
KR (1) KR20010023830A (is)
CN (1) CN1278821A (is)
AP (1) AP2000001760A0 (is)
AU (1) AU9536098A (is)
BR (1) BR9811651A (is)
CA (1) CA2303249A1 (is)
EA (1) EA200000205A1 (is)
EE (1) EE200000137A (is)
GB (1) GB9719187D0 (is)
HR (1) HRP20000136A2 (is)
HU (1) HUP0003475A3 (is)
ID (1) ID24364A (is)
IL (1) IL134935A0 (is)
IS (1) IS5394A (is)
MA (1) MA26544A1 (is)
NO (1) NO20001200L (is)
PL (1) PL339186A1 (is)
SK (1) SK3242000A3 (is)
TR (1) TR200001026T2 (is)
WO (1) WO1999012931A1 (is)
ZA (1) ZA988162B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
US7745226B2 (en) 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
US7972868B2 (en) 2007-11-28 2011-07-05 Quest Diagnostics Investments Incorporated Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
US7977117B2 (en) 2009-12-03 2011-07-12 Quest Diagnostics Investments Incorprated Vitamin D metabolite determination utilizing mass spectrometry following derivatization
US9034653B2 (en) 2009-12-11 2015-05-19 Quest Diagnostics Investments Inc. Mass spectrometry of steroidal compounds in multiplexed patient samples
JP6113504B2 (ja) 2009-12-11 2017-04-12 クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド 非誘導体化非代謝化ビタミンｄの質量分析法による決定
WO2021053058A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
LT4106757T (lt) 2020-04-16 2023-11-10 Mereo Biopharma 4 Limited Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui
JP2024540952A (ja) 2021-10-20 2024-11-06 メレオ バイオファーマ ４ リミテッド 線維化の治療における使用のための好中球エラスターゼ阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983245A (en) * 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes
GB8512230D0 (en) * 1985-05-14 1985-06-19 Shell Internationale Researche Preparation of carboxylic acid salt
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
JP4163254B2 (ja) 1996-01-03 2008-10-08 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ムチリンのカルバモイルオキシ誘導体および抗細菌剤としてのそれらの使用
EA001437B1 (ru) 1996-03-28 2001-02-26 Глаксо Груп Лимитед Производные пирролопирролона в качестве ингибиторов нейтрофильной эластазы

Also Published As

Publication number Publication date
NO20001200D0 (no) 2000-03-08
EP1019406A1 (en) 2000-07-19
TR200001026T2 (tr) 2000-09-21
EA200000205A1 (ru) 2000-10-30
NO20001200L (no) 2000-05-08
HUP0003475A3 (en) 2002-01-28
WO1999012931A1 (en) 1999-03-18
PL339186A1 (en) 2000-12-04
CN1278821A (zh) 2001-01-03
IS5394A (is) 2000-03-03
KR20010023830A (ko) 2001-03-26
BR9811651A (pt) 2000-08-08
HUP0003475A2 (hu) 2001-09-28
SK3242000A3 (en) 2001-03-12
HRP20000136A2 (en) 2000-08-31
ZA988162B (en) 2000-03-22
IL134935A0 (en) 2001-05-20
JP2001515902A (ja) 2001-09-25
ID24364A (id) 2000-07-13
US6228853B1 (en) 2001-05-08
CA2303249A1 (en) 1999-03-18
AP2000001760A0 (en) 2000-03-31
AU9536098A (en) 1999-03-29
GB9719187D0 (en) 1997-11-12
MA26544A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
FI944804A0 (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
EE9800335A (et) Pürrolopürrolooni derivaadid kui neutrofiilelastaasi inhibiitorid
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
DK0915088T3 (da) D-prolinderivater
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
EP1017682A4 (en) NEW ANGIOGENESIS INHIBITORS
EE200000138A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
PT927183E (pt) Inibidores espirociclicos de metaloproteases
FI973211A7 (fi) Ihmisen leukosyyttielastaasin inhibiittoreina hyödylliset proliinijohd annaiset
FI964781L (fi) Uusia elastaasi-inhibiittoreita
DE69733263D1 (de) Markierte elastase-inhibitoren
HUP0003475A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200100084A (xx) NOS inhibiitorite uued farmatseutilised kasutusv�imalused
EE9900585A (et) 6-asauratsiili derivaadid IL-5 inhibiitoritena
ID23866A (id) Komposisi untuk menyelamatkan beras terhadap asetoklor
ZA988160B (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
SI0891362T1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1026420A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1026210A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1016170A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
BR1100811A (pt) Derivados de 1-metil-carbapenema